Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Manufacturers

Vaccine Manufacturers

VAERS adverse event reports broken down by vaccine manufacturer. These numbers reflect reporting patterns and market presence, not relative safety.

Manufacturer report counts are driven primarily by market share and the types of vaccines produced. Companies producing COVID-19 vaccines dominate recent data due to the unprecedented scale of the vaccination campaign. Comparing manufacturers requires accounting for doses administered, not just raw reports.

47
Manufacturers
In VAERS database
1,983,260
Total Reports
All manufacturers
27,732
Deaths
All manufacturers
143,653
Hospitalizations
All manufacturers

All Manufacturers

ManufacturerTotal Reports ↓DeathsHospitalizationsMarket Share
Pfizer / BioNTech559,25712,67767,66821.2%
Moderna514,56911,51047,95619.5%
Merck & Co.479,9714,15328,96818.2%
Sanofi Pasteur254,7512,99918,5499.7%
GlaxoSmithKline234,4571,99011,2668.9%
Pfizer / Wyeth148,8094,98719,5975.6%
Unknown Manufacturer137,3602,20210,9375.2%
Janssen81,5332,67610,5113.1%
Novartis49,8841832,2101.9%
Connaught Laboratories37,4299894,2321.4%
Smithkline Beecham29,7476902,4131.1%
Seqirus22,3701308590.8%
MedImmune13,362849250.5%
Lederle Laboratories12,3194371,4180.5%
Emergent BioSolutions12,308991,7910.5%
CSL Limited9,844405020.4%
Connaught Ltd.7,0603871,1860.3%
Michigan Dept Pub Hlth3,735302560.1%
Protein Sciences Corporation3,72110900.1%
Berna Biotech, Ltd.3,3134970.1%
Showing 1 to 20 of 47
Page 1 of 3

Top Manufacturers by Reports

These manufacturers have the highest number of VAERS reports. This typically reflects market share and vaccine distribution, not safety profiles.

1. Pfizer / BioNTech
559,257 reports (28.2%)
12,677 deaths
2. Moderna
514,569 reports (25.9%)
11,510 deaths
3. Merck & Co.
479,971 reports (24.2%)
4,153 deaths
4. Sanofi Pasteur
254,751 reports (12.8%)
2,999 deaths
5. GlaxoSmithKline
234,457 reports (11.8%)
1,990 deaths
6. Pfizer / Wyeth
148,809 reports (7.5%)
4,987 deaths

Understanding Manufacturer Data

•Market presence: More reports often mean more vaccines distributed, not necessarily more problems
•Time in market: Companies producing vaccines longer may have accumulated more reports over time
•Vaccine types: Different vaccine types (live vs. inactivated) may have different reporting patterns

Market Share vs. Safety

•COVID-19 impact: COVID vaccine manufacturers dominate recent reports due to mass vaccination campaigns
•Denominator matters: Safety should be evaluated per dose administered, not total reports
•Regulatory oversight: All manufacturers must meet the same FDA safety and efficacy standards